122 related articles for article (PubMed ID: 37709605)
1. A robust genomic-based prognostic model for the assessment of cancer stemness and survival for patients with hepatocellular carcinoma.
Du CL; Wei SY; Chen YH; Chen KJ
Hepatobiliary Pancreat Dis Int; 2024 Feb; 23(1):97-102. PubMed ID: 37709605
[No Abstract] [Full Text] [Related]
2. Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy.
Dhanasekaran R; Nault JC; Roberts LR; Zucman-Rossi J
Gastroenterology; 2019 Jan; 156(2):492-509. PubMed ID: 30404026
[TBL] [Abstract][Full Text] [Related]
3. A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma.
Zhang G; Zhang K; Zhao Y; Yang Q; Lv X
BMC Cancer; 2022 Oct; 22(1):1103. PubMed ID: 36307751
[TBL] [Abstract][Full Text] [Related]
4. Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma.
Lin X; Li AM; Li YH; Luo RC; Zou YJ; Liu YY; Liu C; Xie YY; Zuo S; Liu Z; Liu Z; Fang WY
Signal Transduct Target Ther; 2020 Feb; 5(1):13. PubMed ID: 32296025
[TBL] [Abstract][Full Text] [Related]
5. Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas.
Castven D; Fischer M; Becker D; Heinrich S; Andersen JB; Strand D; Sprinzl MF; Strand S; Czauderna C; Heilmann-Heimbach S; Roessler S; Weinmann A; Wörns MA; Thorgeirsson SS; Galle PR; Matter MS; Lang H; Marquardt JU
Oncotarget; 2017 Jul; 8(30):48688-48700. PubMed ID: 28415775
[TBL] [Abstract][Full Text] [Related]
6. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
Li B; Cao Y; Meng G; Qian L; Xu T; Yan C; Luo O; Wang S; Wei J; Ding Y; Yu D
EBioMedicine; 2019 Jan; 39():239-254. PubMed ID: 30555042
[TBL] [Abstract][Full Text] [Related]
7. LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3.
Shu G; Su H; Wang Z; Lai S; Wang Y; Liu X; Dai L; Bi Y; Chen W; Huang W; Zhou Z; He S; Dai H; Tang B
J Exp Clin Cancer Res; 2021 Jan; 40(1):45. PubMed ID: 33499874
[TBL] [Abstract][Full Text] [Related]
8. Weighted correlation gene network analysis reveals a new stemness index-related survival model for prognostic prediction in hepatocellular carcinoma.
Zhang Q; Wang J; Liu M; Zhu Q; Li Q; Xie C; Han C; Wang Y; Gao M; Liu J
Aging (Albany NY); 2020 Jul; 12(13):13502-13517. PubMed ID: 32644941
[TBL] [Abstract][Full Text] [Related]
9. Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy.
Zhang YP; Bao ZW; Wu JB; Chen YH; Chen JR; Xie HY; Zhou L; Wu J; Zheng SS
Technol Cancer Res Treat; 2020; 19():1533033820944274. PubMed ID: 32715976
[TBL] [Abstract][Full Text] [Related]
10. A predictive and prognostic model for hepatocellular carcinoma with microvascular invasion based TCGA database genomics.
Wang J; Ding ZW; Chen K; Liu YZ; Li N; Hu MG
BMC Cancer; 2021 Dec; 21(1):1337. PubMed ID: 34911488
[TBL] [Abstract][Full Text] [Related]
11. Increased Oxidative Phosphorylation Is Required for Stemness Maintenance in Liver Cancer Stem Cells from Hepatocellular Carcinoma Cell Line HCCLM3 Cells.
Liu G; Luo Q; Li H; Liu Q; Ju Y; Song G
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722385
[TBL] [Abstract][Full Text] [Related]
12. Identification of Cancer Cell Stemness-Associated Long Noncoding RNAs for Predicting Prognosis of Patients with Hepatocellular Carcinoma.
Zhang Q; Cheng M; Fan Z; Jin Q; Cao P; Zhou G
DNA Cell Biol; 2021 Aug; 40(8):1087-1100. PubMed ID: 34096799
[TBL] [Abstract][Full Text] [Related]
13. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
[TBL] [Abstract][Full Text] [Related]
14. High FOXK1 expression correlates with poor outcomes in hepatocellular carcinoma and regulates stemness of hepatocellular carcinoma cells.
Cao H; Chu X; Wang Z; Guo C; Shao S; Xiao J; Zheng J; Zhang D
Life Sci; 2019 Jul; 228():128-134. PubMed ID: 31054270
[TBL] [Abstract][Full Text] [Related]
15. SIRT1 and c-Myc promote liver tumor cell survival and predict poor survival of human hepatocellular carcinomas.
Jang KY; Noh SJ; Lehwald N; Tao GZ; Bellovin DI; Park HS; Moon WS; Felsher DW; Sylvester KG
PLoS One; 2012; 7(9):e45119. PubMed ID: 23024800
[TBL] [Abstract][Full Text] [Related]
16. Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.
Nio K; Yamashita T; Okada H; Kondo M; Hayashi T; Hara Y; Nomura Y; Zeng SS; Yoshida M; Hayashi T; Sunagozaka H; Oishi N; Honda M; Kaneko S
J Hepatol; 2015 Nov; 63(5):1164-72. PubMed ID: 26095183
[TBL] [Abstract][Full Text] [Related]
17. Integrated Machine Learning and Bioinformatic Analyses Constructed a Novel Stemness-Related Classifier to Predict Prognosis and Immunotherapy Responses for Hepatocellular Carcinoma Patients.
Chen D; Liu J; Zang L; Xiao T; Zhang X; Li Z; Zhu H; Gao W; Yu X
Int J Biol Sci; 2022; 18(1):360-373. PubMed ID: 34975338
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis revealing a novel stemness-metabolism-related gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma.
Wang Y; Wan X; Du S
Front Immunol; 2023; 14():1100100. PubMed ID: 37622118
[TBL] [Abstract][Full Text] [Related]
19. Genomic aberrations in the HTPAP promoter affect tumor metastasis and clinical prognosis of hepatocellular carcinoma.
Wu JC; Jia HL; Li ZR; Zhou KL; Qin LX; Dong QZ; Ren N
PLoS One; 2014; 9(3):e90528. PubMed ID: 24603412
[TBL] [Abstract][Full Text] [Related]
20. A stemness-based eleven-gene signature correlates with the clinical outcome of hepatocellular carcinoma.
Hong L; Zhou Y; Xie X; Wu W; Shi C; Lin H; Shi Z
BMC Cancer; 2021 Jun; 21(1):716. PubMed ID: 34147074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
